These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12634127)

  • 1. Molecular circuits, biological switches, and nonlinear dose-response relationships.
    Andersen ME; Yang RS; French CT; Chubb LS; Dennison JE
    Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):971-8. PubMed ID: 12634127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative mechanistically based dose-response modeling with endocrine-active compounds.
    Andersen ME; Conolly RB; Faustman EM; Kavlock RJ; Portier CJ; Sheehan DM; Wier PJ; Ziese L
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):631-8. PubMed ID: 10421774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species, interindividual, and tissue specificity in endocrine signaling.
    Walker C; Ahmed SA; Brown T; Ho SM; Hodges L; Lucier G; Russo J; Weigel N; Weise T; Vandenbergh J
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):619-24. PubMed ID: 10421772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of endocrine disruptors: approaches, issues, and uncertainties.
    Chen CW
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():20-3. PubMed ID: 11820607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological regulation of receptor-hormone complex concentrations in relation to dose-response assessments for endocrine-active compounds.
    Andersen ME; Barton HA
    Toxicol Sci; 1999 Mar; 48(1):38-50. PubMed ID: 10330682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response assessment strategies for endocrine-active compounds.
    Barton HA; Andersen ME
    Regul Toxicol Pharmacol; 1997 Jun; 25(3):292-305. PubMed ID: 9237331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating quantitative formulas for dose-response assessment of chemical mixtures.
    Hertzberg RC; Teuschler LK
    Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):965-70. PubMed ID: 12634126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
    Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine disrupters: an emerging environmental health problem.
    Rubin CH; Niskar AS
    J Med Assoc Ga; 1999 Dec; 88(4):27-30. PubMed ID: 10666990
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression.
    Li L; Andersen ME; Heber S; Zhang Q
    J Mol Endocrinol; 2007 May; 38(5):569-85. PubMed ID: 17496158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An introduction to the molecular basics of aryl hydrocarbon receptor biology.
    Abel J; Haarmann-Stemmann T
    Biol Chem; 2010 Nov; 391(11):1235-48. PubMed ID: 20868221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring river sediments contaminated predominantly with polyaromatic hydrocarbons by chemical and in vitro bioassay techniques.
    Vondrácek J; Machala M; Minksová K; Bláha L; Murk AJ; Kozubík A; Hofmanová J; Hilscherová K; Ulrich R; Ciganek M; Neca J; Svrcková D; Holoubek I
    Environ Toxicol Chem; 2001 Jul; 20(7):1499-506. PubMed ID: 11434290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of quantitative histological and molecular data for risk assessment and biologically based model development.
    Andersen ME
    Toxicol Pathol; 2002; 30(1):106-11. PubMed ID: 11890460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of environmental endocrine-active substances on public health.
    Koifman S; Paumgartten FJ
    Cad Saude Publica; 2002; 18(2):354-5. PubMed ID: 11923878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endocrine disruptors and allergy].
    Inadera H
    Arerugi; 2005 May; 54(5):451-4. PubMed ID: 16043970
    [No Abstract]   [Full Text] [Related]  

  • 18. Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.
    Watt J; Schlezinger JJ
    Toxicology; 2015 May; 331():66-77. PubMed ID: 25777084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An approach to the development of quantitative models to assess the effects of exposure to environmentally relevant levels of endocrine disruptors on homeostasis in adults.
    Ben-Jonathan N; Cooper RL; Foster P; Hughes CL; Hoyer PB; Klotz D; Kohn M; Lamb DJ; Stancel GM
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):605-11. PubMed ID: 10421770
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.